← back to search

Dawn C. Matthews

AC Diagnostics (United States) · US
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Medical Imaging Techniques and Applications, and Functional Brain Connectivity Studies.
h-index
17
citations
1,707
works
55
NIH funding
primary concept
email

Recent publications

The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
Journal of Nuclear Medicine 2022cited by 23position: lastdoi
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition
Scientific Reports 2021cited by 271position: middledoi
Sex-driven modifiers of Alzheimer risk
Neurology 2020cited by 156position: middledoi
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults
Neurology 2018cited by 243position: middledoi
Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer’s disease: a cross-sectional study of middle-aged adults from the broader New York City area
BMJ Open 2018cited by 80position: middledoi
Associations of lifestyle and vascular risk factors with Alzheimer’s brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area
BMJ Open 2018cited by 45position: middledoi
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Journal of Alzheimer s Disease 2017cited by 101position: middledoi
Dissociation of Down syndrome and Alzheimer's disease effects with imaging
Alzheimer s & Dementia Translational Research & Clinical Interventions 2016cited by 57position: firstdoi
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Alzheimer s & Dementia 2014cited by 125position: middledoi
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study
Advances in Molecular Imaging 2014cited by 70position: firstdoi
Comparing Brain Amyloid Deposition, Glucose Metabolism, and Atrophy in Mild Cognitive Impairment with and without a Family History of Dementia
Journal of Alzheimer s Disease 2013cited by 44position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Lisa Mosconi · Cornell University8 papers (2013–2021)Mony J. de Leon · Cornell University6 papers (2014–2021)Richard Isaacson · Cornell University5 papers (2018–2021) · 5 papers (2013–2018)Randolph Andrews · Weill Cornell Medicine4 papers (2018–2021)Shankar Vallabhajosula · Cornell University3 papers (2014–2018)Ricardo S. Osorio · Nathan Kline Institute for Psychiatric Research3 papers (2018–2018) · 3 papers (2018–2021)Michelle Walters · New York University3 papers (2018–2018)Crystal Quinn · Brooklyn College3 papers (2018–2018) · 3 papers (2014–2017)Joanna Sterling · New York University3 papers (2018–2018)Michael S. Rafii · University of Southern California2 papers (2016–2017)Miles N. Wernick · University of Massachusetts Chan Medical School2 papers (2016–2017)Eva Schelbaum · Center for Discovery2 papers (2020–2021)Seth Ness · National Institute of Neurological Disorders and Stroke2 papers (2016–2017)Hollie Hristov · Institute for Neurodegenerative Disorders2 papers (2020–2021)Valentina Berti · Azienda Ospedaliero-Universitaria Careggi2 papers (2018–2021)Mark E. Schmidt · KU Leuven2 papers (2014–2016)Mony J. de Leon · University of Arizona2 papers (2020–2021)